Uncoupling of gene expression from copy number presents therapeutic opportunities in aneuploid cancers

Mohanty et al. (2021) Cell Reports Medicine. CC BY-NC-ND 4.0

Mohanty et al. (2021) Cell Rep Medicine. CC BY-NC-ND 4.0

Mohanty V, Wang F, Mills GB, CTD² Research Network, Chen K.

Cell Reports Medicine

July 20, 2021

Uncoupling of mRNA expression from copy number (UECN) might be a strategy for cancer cells to a tolerate high degree of aneuploidy. To test the extent and role of UECN across cancers, we perform integrative multiomic analysis of The Cancer Genome Atlas (TCGA) dataset, encompassing ∼5,000 individual tumors. We find UECN is common in cancers and is associated with increased oncogenic signaling, proliferation, and immune suppression. UECN appears to be orchestrated by complex regulatory changes, with transcription factors (TFs) playing a prominent role. To further dissect the regulatory mechanisms, we develop a systems-biology approach to identify candidate TFs, which could serve as targets to disrupt UECN and reduce tumor fitness. Applying our approach to TCGA data, we identify 21 putative targets, 42.8% of which are validated by independent sources. Together, our study indicates that UECN is likely an important mechanism in development of aneuploid tumors and might be therapeutically targetable.

Last updated: July 28, 2021